Healthcare entity
All 1 tracked stories fall under one category: market-trends. Warby Parker Inc. is most often covered alongside David Gilboa, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 3.2 across the same-window beat baseline.
Last mentioned: Feb 27, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: market-trends. Warby Parker Inc. is most often covered alongside David Gilboa, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 3.2 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 5.7 in the same window. Warby Parker Inc. appears in 1 tracked Healthcare story from February 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Warby Parker Inc.. Shared-story counts are live from our verified record — not editorial picks.
Anticipated Milestones
Expected expansion of WRBY's insurance network and SEER's multi-omics software updates.
Market Analysis
Analysts highlight the shift toward integrated health platforms in both consumer and clinical sectors.
Q4 Earnings Calls
Warby Parker and Seer, Inc. both report year-end results, outlining 2026 growth strategies.
Warby Parker and Seer, Inc. reported Q4 2025 results, highlighting a pivot toward integrated health platforms and advanced diagnostic capabilities. While Warby Parker expands its telehealth and physical eye care ecosystem, Seer is accelerating the commercialization of its proteomics technology to redefine precision medicine.
Source: seekingalpha.com · seekingalpha.com
Warby Parker Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
